Also known as Zinacef, Kefurox, Ceftin, Zinnat, and Alti Cefuroxime
Cefuroxime is a parenteral second generation cephalosporin antibiotic. It was discovered by Glaxo now GlaxoSmithKline and introduced in 1978 as Zinacef. It was approved by FDA on 19 Oct 1983. In US it is available as Zinacef by Covis Pharmaceuticals as the company acquired the US rights of the product from GSK. In India it is available as Supacef by GSK. Cefuroxime axetil is an acetoxyetyl ester prodrug of cefuroxime which is effective orally.Source: Wikipedia
Estimated Total Cost: $13.83 for an average of 7 days supply
Patients are most commonly prescribed cefuroxime to treat chronic sinusitis, acute sinusitis, frontal headache, and sinus congestion.